Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder
- PMID: 35547103
- PMCID: PMC9082225
- DOI: 10.4102/sajpsychiatry.v28i0.1786
Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder
Abstract
Background: Substance use disorders (SUDs) continue to be a public health problem. Attention-deficit/hyperactivity disorder (ADHD) is seen as a risk factor for SUD. Prevalence of alcohol and cannabis use amongst adults with SUD and comorbid ADHD impacts both disorders cognitively and behaviourally.
Aim: Our study aimed to compare alcohol and cannabis use between treatment-seeking SUD patients with ADHD and SUD patients without ADHD symptomatology.
Setting: Various rehabilitation centres, including the South African National Council on Alcoholism and Drug Dependence (SANCA) Centres, and Private and Provincial Government Substance Abuse Treatment Centres.
Methods: A cross-sectional study of adults on drug rehabilitation was conducted. Data on socio-demographic information and alcohol and cannabis use from 185 post-detox inpatients were collected. Diagnoses were based on DSM-IV criteria. Attention-deficit/hyperactivity disorder diagnosis was confirmed by the Diagnostic-Interview for ADHD in Adults (DIVA 2.0). SUD+ADHD (n = 52) and SUD-ADHD (n = 128) groups were compared on alcohol and cannabis use as a function of gender.
Results: No significant differences in the use of alcohol between the SUD+ADHD and SUD-ADHD groups were found. However, the SUD+ADHD group showed increased cannabis consumption. Especially, the SUD+ADHD females showed an earlier age of onset of cannabis use than the SUD-ADHD females and revealed that they use cannabis for a longer period compared with the SUD-ADHD females and SUD+ADHD and SUD-ADHD males.
Conclusion: The results revealed the relationship between ADHD and cannabis use, especially amongst females with ADHD and reinforce the need to consider ADHD in cannabis use SUD in clinical interventions.
Keywords: ADHD; ASRS; DIVA; South Africa; alcohol; cannabis; self-medication.
© 2022. The Authors.
Conflict of interest statement
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Similar articles
-
Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.Eur Addict Res. 2023;29(1):9-18. doi: 10.1159/000526386. Epub 2022 Nov 4. Eur Addict Res. 2023. PMID: 36349763
-
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.BMC Psychiatry. 2022 Sep 23;22(1):625. doi: 10.1186/s12888-022-04259-6. BMC Psychiatry. 2022. PMID: 36151539 Free PMC article.
-
Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.Drug Alcohol Rev. 2015 Nov;34(6):683-93. doi: 10.1111/dar.12249. Epub 2015 Mar 18. Drug Alcohol Rev. 2015. PMID: 25790353
-
Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.Curr Pharm Des. 2015;21(23):3359-66. doi: 10.2174/1381612821666150619093254. Curr Pharm Des. 2015. PMID: 26088112 Review.
-
Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD).Expert Opin Pharmacother. 2019 Feb;20(3):343-355. doi: 10.1080/14656566.2018.1551878. Epub 2018 Dec 4. Expert Opin Pharmacother. 2019. PMID: 30513231 Review.
Cited by
-
Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review.Cureus. 2023 Jun 26;15(6):e40969. doi: 10.7759/cureus.40969. eCollection 2023 Jun. Cureus. 2023. PMID: 37503496 Free PMC article. Review.
-
Exploring the Link Between Attention-Deficit Hyperactivity Disorder and Cannabis Use Disorders: A Review.Med Sci Monit. 2023 May 6;29:e939749. doi: 10.12659/MSM.939749. Med Sci Monit. 2023. PMID: 37147797 Free PMC article. Review.
References
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (DSM-5®) (5th ed.). Arlington, VA: American Psychiatric Publishing; 2013.
LinkOut - more resources
Full Text Sources